Possible Involvement of Chemokine‐induced Platelet Activation in Thrombophilic Diathesis of Antiphospholipid Syndrome
- 1 September 2009
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1173 (1) , 137-145
Abstract
Among the heterogeneous antiphospholipid antibodies, many studies suggest that those directed to β2‐glycoprotein I (β2GPI) are the major pathogenic antibodies in antiphospholipid syndrome (APS). They have been shown to activate the coagulation pathway via several mechanisms, activate platelets via thrombin formation, and suppress fibrinolysis. Additionally, we propose another possible mechanism that involves certain chemokines and results in platelet activation. This hypothesis is based on the observations that anti‐β2GPI antibodies stimulated monocytes to secrete inflammatory cytokines such as IL‐1β and TNF‐α, which in turn stimulated vascular endothelial cells to express chemokines such as CX3CL1 and CCL5. CX3CL1 increased the ability of normal platelets to adhere to collagen at a high shear rate, while CCL5 induced platelet aggregation. Expression of tissue factor, IL‐1β, and TNF‐α by monocytes stimulated with anti‐β2GPI antibodies, as well as CX3CL1 and CCL5 by vascular endothelial cells stimulated with IL‐1β or TNF‐α were all suppressed by the NF‐κB–specific inhibitor DHMEQ. These results suggest that the NF‐κB pathway may be a potential therapeutic target relating to both the coagulation pathway and platelet activity.Keywords
This publication has 24 references indexed in Scilit:
- Platelet Chemokines in Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunityJournal of Autoimmunity, 2008
- Insights into atherosclerosis therapy in antiphospholipid syndromeAutoimmunity Reviews, 2007
- NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factorArthritis Research & Therapy, 2007
- 1,25(OH)2D3 blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-κBLaboratory Investigation, 2007
- Some antiphospholipid antibodies recognize conformational epitopes shared by β2‐glycoprotein I and the homologous catalytic domains of several serine proteasesArthritis & Rheumatism, 2007
- New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen γ-chain dodecapeptide- or glycoprotein Ibα-conjugated latex beads under flow conditionsJournal of Artificial Organs, 2006
- Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF‐κB/Rel proteins via the p38 mitogen‐activated protein kinase pathway, and of the MEK‐1/ERK pathwayArthritis & Rheumatism, 2005
- Immunocytochemical studies on co-localization of -granule membrane IIb 3 integrin and intragranular fibrinogen of human platelets and their cell-surface expression during the thrombin-induced release reactionJournal of Electron Microscopy, 2003
- Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by DehydroxymethylepoxyquinomicinJournal of Biological Chemistry, 2002